berberine has been researched along with Infections, Helicobacter in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 7 (70.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, N; Chen, S; Hu, S; Liu, Q; Ma, X; Shen, C; Tang, J; Wang, J; Xiang, J; Zeng, J; Zhang, Y | 1 |
| Chen, S; Dong, Q; Liu, Y; Shen, W; Shi, Y | 1 |
| Huang, T; Jiao, B; Li, X; Ma, H; Tang, Q; Tang, X; Wang, R; Wu, H; Xie, X; Ye, X; Zhu, X | 1 |
| Bao, C; Cai, H; Chen, X; Li, H; Li, R; Wang, R; Wei, S; Wen, J; Wu, S; Yang, T; Yang, X; Zhang, J; Zhao, Y | 1 |
| Han, C; Hao, C; Liu, N; Lu, WQ; Ma, JP; Shi, YQ; Wang, JH; Wang, N; Wang, YX; Wu, SR; Yuan, DH; Zhang, J | 1 |
| Chen, X; Hu, H; Li, P; Rao, Y; Shen, Y; Sun, Y; Yang, X; Zou, Y | 1 |
| Chen, X; Li, J; Liu, H; Wang, L; Wang, R; Wu, S; Yang, T; Yang, X; Zhao, Y | 1 |
| Chen, Y; Ke, L; Li, CJ; Liang, J; Ni, Z; Shang, L; Shi, YQ; Zhang, D; Zhang, LH; Zhu, SH | 1 |
| Dang, Z; Jia, Y; Li, X; Wu, X | 1 |
| Chang, CH; Chang, SJ; Chen, YS; Chou, SC; Chung, CC; Lin, JH; Lin, YH | 1 |
1 review(s) available for berberine and Infections, Helicobacter
| Article | Year |
|---|---|
Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa's cascade underlie its therapeutic effects.
Topics: Anti-Bacterial Agents; Berberine; Carcinogenesis; Cytokines; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Humans; Inflammation; NF-kappa B; Phosphatidylinositol 3-Kinases; Precancerous Conditions; Proto-Oncogene Proteins c-akt; Stomach Neoplasms | 2022 |
3 trial(s) available for berberine and Infections, Helicobacter
| Article | Year |
|---|---|
Efficacy and safety of triple therapy containing berberine, amoxicillin, and vonoprazan for Helicobacter pylori initial treatment: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Berberine; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2023 |
A randomized, multicenter and noninferiority study of amoxicillin plus berberine vs tetracycline plus furazolidone in quadruple therapy for Helicobacter pylori rescue treatment.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Berberine; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Tetracycline; Treatment Outcome | 2020 |
Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial.
Topics: Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Berberine; Bismuth; Body Mass Index; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Proton Pump Inhibitors; Severity of Illness Index; Sex Factors | 2017 |
6 other study(ies) available for berberine and Infections, Helicobacter
| Article | Year |
|---|---|
Epiberberine inhibits Helicobacter pylori and reduces host apoptosis and inflammatory damage by down-regulating urease expression.
Topics: Animals; Berberine; Helicobacter Infections; Helicobacter pylori; Inflammation; Molecular Docking Simulation; Urease | 2024 |
Mechanism of berberine in treating Helicobacter pylori induced chronic atrophic gastritis through IRF8-IFN-γ signaling axis suppressing.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Cell Line; Cell Proliferation; Cell Survival; Chemokine CXCL1; Chemokine CXCL9; Chronic Disease; Disease Models, Animal; Epithelial Cells; Gastritis, Atrophic; Gene Expression Regulation; Helicobacter Infections; Helicobacter pylori; Humans; Interferon Regulatory Factors; Interferon-gamma; Interleukin-17; Male; NLR Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; Uridine Phosphorylase | 2020 |
Antibacterial self-assembled nanodrugs composed of berberine derivatives and rhamnolipids against Helicobacter pylori.
Topics: Animals; Anti-Bacterial Agents; Berberine; Biofilms; Glycolipids; Helicobacter Infections; Helicobacter pylori; Mice | 2020 |
Berberine regulates macrophage polarization through IL-4-STAT6 signaling pathway in Helicobacter pylori-induced chronic atrophic gastritis.
Topics: Animals; Berberine; Gastritis, Atrophic; Gene Expression Regulation; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-4; Macrophage Activation; Male; Mice; Rats; STAT6 Transcription Factor | 2021 |
Berberine demonstrates anti-inflammatory properties in Helicobacter pylori-infected mice with chronic gastritis by attenuating the Th17 response triggered by the B cell-activating factor.
Topics: Animals; Anti-Inflammatory Agents; B-Cell Activating Factor; Berberine; Cells, Cultured; Chronic Disease; Cytokines; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Interleukin-17; Macrophages; Male; Mice; Mice, Inbred C57BL; Th17 Cells | 2018 |
Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study.
Topics: Animals; Berberine; Chitosan; Drug Delivery Systems; Fucose; Helicobacter Infections; Helicobacter pylori; Heparin; Humans; Mice; Microscopy, Confocal; Nanoparticles | 2015 |